M2GEN . . . THE FUTURE OF PERSONALIZED MEDICINE Trademark

Trademark Overview

On Wednesday, June 16, 2010, a trademark application was filed for M2GEN . . . THE FUTURE OF PERSONALIZED MEDICINE with the United States Patent and Trademark Office. The USPTO has given the M2GEN . . . THE FUTURE OF PERSONALIZED MEDICINE trademark a serial number of 85064599. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 23, 2012. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The M2GEN . . . THE FUTURE OF PERSONALIZED MEDICINE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services; Medical services, namely, providing a database featuring medical information for matching particular patients to a therapy or trial by the specific molecular signature of the patient
m2gen . . . the future of personalized medicine

General Information

Serial Number85064599
Word MarkM2GEN . . . THE FUTURE OF PERSONALIZED MEDICINE
Filing DateWednesday, June 16, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 23, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2010

Trademark Statements

Goods and ServicesMedical services; Medical services, namely, providing a database featuring medical information for matching particular patients to a therapy or trial by the specific molecular signature of the patient
Pseudo MarkM TWO GEN . . . THE FUTURE OF PERSONALIZED MEDICINE

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2010
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33612
Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Trademark Events

Event DateEvent Description
Monday, July 23, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 23, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 11, 2011EXTENSION 2 GRANTED
Thursday, December 8, 2011EXTENSION 2 FILED
Thursday, December 8, 2011TEAS EXTENSION RECEIVED
Wednesday, June 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 7, 2011EXTENSION 1 GRANTED
Friday, June 3, 2011EXTENSION 1 FILED
Tuesday, June 7, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 3, 2011TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2010PUBLISHED FOR OPPOSITION
Friday, September 17, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 15, 2010ASSIGNED TO LIE
Saturday, September 4, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 3, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 3, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 3, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 1, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2010NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2010NON-FINAL ACTION WRITTEN
Thursday, August 26, 2010ASSIGNED TO EXAMINER
Wednesday, June 23, 2010NOTICE OF PSEUDO MARK MAILED
Tuesday, June 22, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicine personalized future medical services trial therapy specific molecular patient signature patients matching